[Coexistence of scleroderma-like syndrome and idiopathic myelofibrosis in a 54-year-old female patient: case report]

Pol Arch Med Wewn. 2007 Aug;117(8):370-3.
[Article in Polish]

Abstract

Systemic sclerosis (SSc) is characterized by immunological disturbances, vascular damage and overproduction of extracellular matrix by stimulated fibroblasts. It has been postulated that immunological reactions involved in the pathogenesis of SSc may promote the development of malignancies. Coexistence of this disease with neoplasmatic processes is relatively frequent. In our report we describe a case a 54-year-old woman with scleroderma-like syndrome, which has preceded the occurrence of idiopathic myelofibrosis by many years. Owing to multiple repeated diagnostic tests we managed to diagnose this disease at the early stage, which enabled effective therapy with remission of blood dyscrasia as well as inhibition of skin lesions and lung fibrosis.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Azathioprine / therapeutic use
  • Female
  • Glucocorticoids / therapeutic use*
  • Humans
  • Hydroxyurea / therapeutic use
  • Immunosuppressive Agents / therapeutic use*
  • Middle Aged
  • Prednisone / therapeutic use
  • Primary Myelofibrosis / complications*
  • Primary Myelofibrosis / diagnosis
  • Primary Myelofibrosis / drug therapy*
  • Raynaud Disease / complications
  • Raynaud Disease / diagnosis
  • Scleroderma, Systemic / complications*
  • Scleroderma, Systemic / diagnosis
  • Scleroderma, Systemic / drug therapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Glucocorticoids
  • Immunosuppressive Agents
  • Azathioprine
  • Prednisone
  • Hydroxyurea